121 related articles for article (PubMed ID: 31504936)
1. Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.
Parra S; Heras M; Herrero P; Amigó N; Garcés E; Girona J; Correig X; Canela N; Castro A
Rheumatology (Oxford); 2020 Mar; 59(3):650-661. PubMed ID: 31504936
[TBL] [Abstract][Full Text] [Related]
2. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
[TBL] [Abstract][Full Text] [Related]
3. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
5. Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
Noren Hooten N; Mode NA; Kowalik E; Omoniyi V; Zonderman AB; Ezike N; DiNubile MJ; Levinson SL; Evans MK
J Transl Med; 2023 Mar; 21(1):190. PubMed ID: 36899335
[TBL] [Abstract][Full Text] [Related]
6. Plasma Gelsolin Level in HIV-1-Infected Patients: An Indicator of Disease Severity.
Sinha KK; Peddada N; Jha PK; Mishra A; Pandey K; Das VN; Ashish ; Das P
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):254-260. PubMed ID: 27700141
[TBL] [Abstract][Full Text] [Related]
7. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
Madda R; Lin SC; Sun WH; Huang SL
J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
[TBL] [Abstract][Full Text] [Related]
8. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
9. Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
Audley J; Gliniewicz EF; Zarember KA; Hong HS; Wald G; Kuhns DB; Kang E; Malech HL; Suffredini AF; Noveck RJ; Dinubile MJ; Levinson SL; Stossel TP; Gallin JI
Inflammation; 2021 Feb; 44(1):270-277. PubMed ID: 32886268
[TBL] [Abstract][Full Text] [Related]
10. Gelsolin levels in patients with bronchiolitis.
Hüsrevoğlu-Esen F; Altuner-Torun Y; Karakükçü Ç; Köse S; Şehriyaroğlu A; Kafadar D; Esen A; Köse M
Turk J Pediatr; 2018; 60(3):286-289. PubMed ID: 30511541
[TBL] [Abstract][Full Text] [Related]
11. Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.
Tydén H; Lood C; Jönsen A; Gullstrand B; Kahn R; Linge P; Kumaraswamy SB; Dahlbäck B; Bengtsson AA
Arthritis Res Ther; 2019 May; 21(1):110. PubMed ID: 31046824
[TBL] [Abstract][Full Text] [Related]
12. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns].
Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY
Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203
[TBL] [Abstract][Full Text] [Related]
13. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.
Rovin BH; Song H; Hebert LA; Nadasdy T; Nadasdy G; Birmingham DJ; Yung Yu C; Nagaraja HN
Kidney Int; 2005 Oct; 68(4):1825-33. PubMed ID: 16164660
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients.
Pinna S; Pasella S; Deiana M; Baralla A; Mannu A; Masala AGE; Pileri PV; Deiana N; Scognamillo F; Pala C; Zinellu A; Carru C; Deiana L
J Immunol Methods; 2017 Jul; 446():37-46. PubMed ID: 28390925
[TBL] [Abstract][Full Text] [Related]
15. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
16. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
17. Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R
J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
Liu L; Zhang T; Ye Y; Zhang S; Chen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
[TBL] [Abstract][Full Text] [Related]
19. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
[TBL] [Abstract][Full Text] [Related]
20. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
